Discover HEMANGEOL
HEMANGEOL (propranolol hydrochloride) oral solution is indicated for the treatment of proliferating infantile hemangiomas that require systemic therapy.
Proven Efficacy
- 60% of patients reached complete or nearly complete resolution of infantile hemangioma by 6 months, versus 4% of patients on placebo. (n=101)1
- 88% of patients on HEMANGEOL showed improvement after 5 weeks of treatment.*
**Based on independent-investigator assessment of telangiectasis, color, textural change, and distortion of anatomical landmarks or skin contours compared to baseline. (n=55)2
BID Dosing
- 3.4 mg/kg divided into 2 daily doses for 6 months was identified as the optimal maintenance dose in a double-blind clinical trial.1
- Dosing Chart for determining the appropriate dose for your patients.
Safety Profile
- Fewer than 2% of patients discontinued treatment due to adverse reactions1
- The most frequently reported adverse reactions (>10%) in infants treated with HEMANGEOL were sleep disorders, aggravated respiratory tract infections such as bronchitis and bronchiolitis associated with cough and fever, diarrhea, and vomiting.
1. Hemangeol Prescribing Information
*Based on independent-investigator assessment of telangiectasis, color, textural change and distortion of anatomical landmarks or skin contours compared to baseline
*Of patients on HEMANGEOL 3.4 mg/kg/day for 6 months who were considered successes, 10% required retreatment for recurrence of hemangiomas.
What is HEMANGEOL?
- HEMANGEOL is a prescription medicine used to treat proliferating infantile hemangioma that requires systemic therapy. To get started with HEMANGEOL, follow the get started button.
HEMANGEOL Dosing Chart
Our Dosing Chart provides weight-based dosing (kg) by Week 1, Week 2, and Week 3 (maintenance dose). Download the chart below for your records.
HEMANGEOL Dosing Calculator
Alcohol Pediatric Guidelines
How much is too much when the pediatric minimal alcohol dose for toxicity is unknown?
Healthcare Provider Resources
Providing The Best for Your Patients
We provide published data and patient education materials for healthcare providers to use with patients and their caregivers. If you have questions about these resources, please contact us.
2026 Eton Pharmaceuticals. 2566-v1